Come on in, the water's warm
Start reading Exits & Outcomes today
For now, subscriptions are differentiated solely based on the number of seats. All Packages Include:
Access to long-form, investigative case studies of digital health companies, including UnitedHealth Group, Omada Health, Pear Therapeutics, Virgin Pulse, and Evidation Health.
Every other Wednesday, E&O digs into digital health companies that sell to self-insured employers and others that rely on enrollment-based distribution. Digital health stacks at Fortune 500s, enrollment tactics, strategy shifts, customer wins, and more.
Updates, insights, scoops and maybe a few rumors hit your inbox each week. The latest developments in digital therapeutics and other regulated, clinically-proven digital health.
Each Monday, E&O publishes the world’s most complete weekly health tech funding round-up, which includes an average of 26 deals (both announced and unannounced). Plus: E&O’s popular health tech trivia challenge.
Searchable, sortable data sheets that track prescription digital therapeutic pipelines, digital diabetes prevention programs and more.
"Unsolicited plug. I can't believe how good the digital health content from Exits & Outcomes is. So much more sophisticated than most other content out there on digital health and digital therapeutics. The subscription price is a total steal (don't tell Brian I said that)."
"Congrats on the new venture – and perfect timing, as you had with MobiHealthNews. Your depth of research is refreshing, not simply regurgitating other researchers’ data. You have covered important behind-the-scenes topics that I have not seen anyone else uncover."
"Brian’s one of the very few pure analysts who have a skill for sorting industry happenings without the advantage of insider knowledge."
"Your new newsletter is OUTSTANDING. I have recommended it to many and have subscribed. Well done."
"Another great in-depth analysis (this time of Omada Health) by Brian Dolan. For folks following digital health, I highly recommend a subscription."
"This report on enrollment tactics and outcomes from Brian Dolan's Exits & Outcomes is [thumbs up emoji]. If you are not yet a subscriber, you should be."
"+1 on subscribing to E&O. I look forward to every issue!"
"If you haven't seen Exits & Outcomes brought to us weekly by Brian Dolan, I highly recommend signing up. P.S. the subscription is worth it!"
"It's worth spending $200 to subscribe to Brian Dolan's Exits & Outcomes... he's certainly digging in interesting places."
Before making your purchase, please read the Terms & Conditions.
Please email me at email@example.com with any questions, comments or request.
Get the student rate, (but expect an email from me to verify).